|
UBXN7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.704200E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.636400E-04 |
| Normal-vs-Stage2 |
3.993200E-01 |
| Normal-vs-Stage3 |
3.294800E-01 |
| Normal-vs-Stage4 |
2.094200E-01 |
| Stage1-vs-Stage2 |
3.759400E-01 |
| Stage1-vs-Stage3 |
3.517600E-01 |
| Stage1-vs-Stage4 |
9.288600E-01 |
| Stage2-vs-Stage3 |
9.679400E-01 |
| Stage2-vs-Stage4 |
5.716000E-01 |
| Stage3-vs-Stage4 |
5.934000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.601500E-03 |
| Normal-vs-AfricanAmerican |
1.629670E-02 |
| Normal-vs-Asian |
2.278300E-03 |
| Caucasian-vs-AfricanAmerican |
9.002400E-01 |
| Caucasian-vs-Asian |
3.975400E-01 |
| AfricanAmerican-vs-Asian |
3.892800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.63717999999147E-05 |
| Normal-vs-Female |
4.622000E-01 |
| Male-vs-Female |
3.567900E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.812500E-02 |
| Normal-vs-Extreme_Weight |
1.73429999994479E-06 |
| Normal-vs-Obese |
2.376200E-01 |
| Normal-vs-Extreme_Obese |
1.399760E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.361400E-01 |
| Normal_Weight-vs-Obese |
3.321400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.446800E-01 |
| Extreme_Weight-vs-Obese |
6.900900E-03 |
| Extreme_Weight-vs-Extreme_Obese |
5.798400E-01 |
| Obese-vs-Extreme_Obese |
4.232800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.971200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.384800E-01 |
| Normal-vs-Age(61-80Yrs) |
3.78739999999933E-05 |
| Normal-vs-Age(81-100Yrs) |
2.73740000000799E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.763400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.416400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.828100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.502040E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.034600E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.229700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.439600E-04 |
| Normal-VS-Type2 PRCC |
1.400520E-03 |
| Normal-VS-KIRP CIMP |
3.927600E-01 |
| Normal-VS-Unclassified PRCC |
7.030000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.638600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.862200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.630500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.992000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.074000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.491000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.83740000003763E-06 |
| Normal-vs-N1 |
7.606200E-01 |
| Normal-vs-N2 |
7.608000E-01 |
| N0-vs-N1 |
4.627700E-02 |
| N0-vs-N2 |
5.521600E-01 |
| N1-vs-N2 |
8.466200E-01 |
|
|
